Condition: Bone Fracture · Sponsor: BonusBio Group Ltd
The purpose of this clinical study is to evaluate the safety and the efficacy of BonoFill-II as an autologous bone-regenerating graft in the reconstruction of deficient bone in two clinical indications: 1. Long and short bone extra-articular comminuted fracture 2. Long and short bones extra and intra articular defect /Gap or non-union, incapable of self-regeneration
This description comes directly from the study's public registry record.
Nimrod Rozen, MD, PhD · +972-4-649-4201 · nimrod_rozen@hotmail.com
Vered Kivity, PhD, MBA · +972-73-206-7103 · veredki@bonus-bio.com
Always discuss trial participation with your own doctor first.
| Emek Medical Center | Afula, Israel | Recruiting |
| Barzilai Medical Center | Ashkelon, Israel | Recruiting |
| Hillel Yafe | Hadera, Israel | Recruiting |
| Carmel Medical Center | Haifa, Israel | Recruiting |
| Rambam Health Campus | Haifa, Israel | Recruiting |
| Meir Medical Center | Kfar Saba, Israel | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03024008